Literature DB >> 26994363

Magnetic resonance imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: Pattern refinement and implications for clinical trials.

Giorgio Tasca1, Mauro Monforte2, Pierfrancesco Ottaviani3, Marco Pelliccioni4, Roberto Frusciante2, Francesco Laschena3, Enzo Ricci2.   

Abstract

OBJECTIVE: Therapeutic perspectives have brought attention to the development of instruments to accurately evaluate the degree of pathology in patients with facioscapulohumeral muscular dystrophy. We aimed to analyze the type and extent of muscle involvement on magnetic resonance imaging (MRI) in a large cohort of patients representative of the broad clinical spectrum of this disease.
METHODS: Pelvic and lower limb muscle MRI scans of 269 symptomatic individuals and 19 nonpenetrant gene carriers were assessed. Comparative analysis of the upper girdle scan in 181 of these subjects was also performed.
RESULTS: We found a peculiar susceptibility and resistance of particular muscles. Combined involvement of abdominal and hamstring muscles with iliopsoas sparing is common in facioscapulohumeral muscular dystrophy (67% of the patients). Adductor longus and/or rectus femoris, whose involvement can go clinically undetected, are often typically affected in early disease (69% of patients younger than 45 years). The extent of lesions on lower limb MRI showed a high correlation with overall clinical severity. One-fourth of the nonpenetrant gene carriers showed abnormalities on MRI. Hyperintensities on short-tau inversion recovery sequences, markers of active disease, were found in muscles without signs of fatty replacement in 35% of patients, representing early lesions.
INTERPRETATION: Our large-scale cross-sectional data provide preliminary evidence for the usefulness of MRI in clinical trials, and set the baseline for longitudinal studies. Muscle MRI can also be used for distinguishing facioscapulohumeral muscular dystrophy from other myopathies in selected cases. Finally, our results are consistent with a model that configures facioscapulohumeral muscular dystrophy as a "muscle-by-muscle" disease. Ann Neurol 2016;79:854-864.
© 2016 American Neurological Association.

Entities:  

Year:  2016        PMID: 26994363     DOI: 10.1002/ana.24640

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  30 in total

Review 1.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

2.  MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.

Authors:  Grete Andersen; Julia R Dahlqvist; Christoffer R Vissing; Karen Heje; Carsten Thomsen; John Vissing
Journal:  J Neurol       Date:  2016-12-20       Impact factor: 4.849

Review 3.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

4.  Adding quantitative muscle MRI to the FSHD clinical trial toolbox.

Authors:  Karlien Mul; Sanne C C Vincenten; Nicol C Voermans; Richard J L F Lemmers; Patrick J van der Vliet; Silvère M van der Maarel; George W Padberg; Corinne G C Horlings; Baziel G M van Engelen
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

5.  An instrumented timed up and go in facioscapulohumeral muscular dystrophy.

Authors:  Jessie Huisinga; Adam Bruetsch; Ayla Mccalley; Melissa Currence; Laura Herbelin; Omar Jawdat; Mamatha Pasnoor; Mazen Dimachkie; Richard Barohn; Jeffrey Statland
Journal:  Muscle Nerve       Date:  2017-10-06       Impact factor: 3.217

6.  Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.

Authors:  Mauro Monforte; Guido Primiano; Gabriella Silvestri; Massimiliano Mirabella; Marco Luigetti; Cristina Cuccagna; Enzo Ricci; Serenella Servidei; Giorgio Tasca
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

Review 7.  MR imaging of inherited myopathies: a review and proposal of imaging algorithms.

Authors:  Laís Uyeda Aivazoglou; Julio Brandão Guimarães; Thomas M Link; Maria Alice Freitas Costa; Fabiano Nassar Cardoso; Bruno de Mattos Lombardi Badia; Igor Braga Farias; Wladimir Bocca Vieira de Rezende Pinto; Paulo Victor Sgobbi de Souza; Acary Souza Bulle Oliveira; Alzira Alves de Siqueira Carvalho; André Yui Aihara; Artur da Rocha Corrêa Fernandes
Journal:  Eur Radiol       Date:  2021-04-21       Impact factor: 5.315

8.  Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy.

Authors:  Giorgio Tasca; Mauro Monforte; Maddalena Corbi; Giuseppe Granata; Donatella Lucchetti; Alessandro Sgambato; Enzo Ricci
Journal:  Mol Neurobiol       Date:  2017-04-29       Impact factor: 5.590

9.  Facioscapulohumeral muscular dystrophy functional composite outcome measure.

Authors:  Katy Eichinger; Chad Heatwole; Stanley Iyadurai; Wendy King; Lindsay Baker; Susanne Heininger; Amy Bartlett; Nuran Dilek; William B Martens; Michael Mcdermott; John T Kissel; Rabi Tawil; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2018-01-30       Impact factor: 3.217

10.  Multi-slice MRI reveals heterogeneity in disease distribution along the length of muscle in Duchenne muscular dystrophy.

Authors:  Stephen M Chrzanowski; Celine Baligand; Rebecca J Willcocks; Jasjit Deol; Ilona Schmalfuss; Donovan J Lott; Michael J Daniels; Claudia Senesac; Glenn A Walter; Krista Vandenborne
Journal:  Acta Myol       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.